What we offer

Ceria develops innovative drug products to eliminate downstream consequences and restore the body’s natural healing. In addition to these therapeutic programs, Ceria provides comprehensive synthetic RNA and nanoparticle manufacturing capabilities—including scalable production, solid inorganic nanoparticle synthesis, and analytical methods. Capabilities include aerosolized drug formulation, particle characterization, and preclinical testing. These combine to enable product development support from pilot research through GMP production.

Inflammatory conditions often share the same root cause.

Advanced Wound Care

Critical Care

Gastrointestinal Care

Latest News

NIH Award

Ceria Therapeutics, Inc. Awarded a $2,000,000 SBIR Grant to Advance Development of a Novel Treatment for Non-healing Diabetic Foot Ulcers

More info

Department of Defense Award

Ceria Therapeutics, Inc. Awarded a $3,800,000 DoD Contract to Advance Development of a Novel Treatment for Acute Lung Injuries

More info

Publications

Photopolymerized Zwitterionic Hydrogels with a Sustained Delivery of Cerium Oxide Nanoparticle-miR146a Conjugate Accelerate Diabetic Wound Healing

More info
View All News

Together, we can accelerate innovation and bring meaningful therapies to patients who need them most.

Ceria is in an exciting stage of growth as we advance our drug candidates toward key development milestones. We welcome collaboration and dialogue with those interested in supporting our mission — whether through investment, strategic partnership, or scientific engagement.

To learn more or explore opportunities to get involved, contact our team at info@ceriatx.com.

Email Us

Ceria Therapeutics

Tucson, AZ | San Juan, PR